Skip to main content

Table 1 Characteristics of the subjects at the baseline

From: The associations of the number of medications and the use of anticholinergics with recovery from tubal feeding: a longitudinal hospital-based study

  All subjects Recovery group Non-recovery group P value
(N = 95) (N = 36) (N = 59) (recovery vs. non-recovery groups)
Sex (men/women) 34/61 13/23 21/38 1.000
Age (years) 84 (61–98) 81.5 (62–96) 86 (61–98) 0.069
Number of prescribed medications 5 (0–16) 5 (0–14) 6 (0–16) 0.401
ACBs 1 (0–6) 0 (0–6) 1 (0–4) 0.654
Route of tubal feeding (nasal/gastrostomy) 62/33 26/10 36/23 0.375
Cerebrovascular disease 71 (74.7%) 28 (77.8%) 43 (72.9%) 0.635
Wasting syndrome 39 (41.1%) 16 (44.4%) 23 (39.0%) 0.669
Parkinson’s disease 10 (10.5%) 2 (5.6%) 8 (13.6%) 0.310
Barthel index
 0–20 92 (96.8%) 34 (94.4%) 58 (98.3%) 0.141
 21–40 1 (1.1%) 0 (0%) 1 (1.7%)  
  > 40 2 (2.1%) 2 (5.6%) 0 (0%)  
HDS-R
 0–10 84 (88.4%) 28 (77.8%) 56 (94.9%) 0.068
 11–20 7 (7.4%) 6 (16.7%) 1 (1.7%)  
  > 20 4 (4.2%) 2 (5.6%) 2 (3.4%)  
  1. The data are presented as the median [range] or number (%)
  2. ACBs Anticholinergic cognitive burden scale, HDS-R Hasegawa dementia rating scale-revised
  3. The recovery group represents the patients who recovered from tubal to oral feeding for all three meals per day during the observation period
\